Related Topics
Harvard School of Public Health professor Barry R. Bloom named recipient of national award for contributions to understanding immune responses to infectious diseases
For immediate release: September 2, 2009 Boston, MA -- Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Harvard School of Public Health (HSPH), will receive…
The cost of South Africa's misguided AIDS policies
[ Spring 2009 ] The human cost of South Africa's misguided AIDS policies AIDS activists and researchers argued for years that the negligent HIV/AIDS policies of former South African President Thabo Mbeki were causing a massive, unconscionable loss of human life. Now,…
Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
For immediate release: Monday, October 20, 2008 Boston, MA - More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert…
TB superstrains
[ Fall 2008 ] Extensively drug-resistant tuberculosis is research focus Covering 200 square kilometers of arid scrubland in South Africa’s KwaZulu-Natal Province, the rural district of Tugela Ferry seems to swallow its inhabitants, its parched mountain ridges shutting out the…
Thomas H. Weller, Nobel Laureate and Professor Emeritus, dies
For immediate release: Tuesday, August 26, 2008 Boston, MA -- Thomas H. Weller, a Nobel Prize winner in 1954 and HSPH Professor Emeritus, passed away on Saturday, August 23, 2008. He was 93. Dr. Weller received the Nobel Prize…
Cervical cancer prevention in U.S. should focus on vaccinating adolescent girls and revising screening policies
For immediate release: Wednesday, August 20, 2008 Boston, MA -- The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in…
Hope for a needle-free TB vaccine
[ Spring 2008 ] New "dry-spray" technology passes muster in guinea pigs Aiming to make immunization safer and more cost-effective for the developing world, Harvard School of Public Health Dean Barry R. Bloom and two bioengineers at Harvard, David Edwards and doctoral…
A low-tech way to combat HIV/AIDS
[ Spring 2008 ] The world is finally waking up to male circumcision The Harvard School of Public Health’s Daniel Halperin has been something of a maverick in the field of HIV/AIDS research. A medical anthropologist and an epidemiologist—one who scours populations…
Inhaled tuberculosis vaccine more effective than traditional shot in study using experimental animals
For Immediate Release: March 12, 2008 Boston, MA -- A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental…
